Harbin Pharmaceutical Group Co Ltd

SHG:600664 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.18 Billion
CN¥8.66 Billion CNY
Market Cap Rank
#9261 Global
#1851 in China
Share Price
CN¥3.44
Change (1 day)
-4.18%
52-Week Range
CN¥3.33 - CN¥4.08
All Time High
CN¥8.34
About

Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, anti-virus and anti-infection, cere… Read more

Harbin Pharmaceutical Group Co Ltd (600664) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.030x

Based on the latest financial reports, Harbin Pharmaceutical Group Co Ltd (600664) has a cash flow conversion efficiency ratio of -0.030x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-192.19 Million) by net assets (CN¥6.41 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Harbin Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Harbin Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Harbin Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Harbin Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Harbin Pharmaceutical Group Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Harbin Pharmaceutical Group Co Ltd from 1998 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥6.09 Billion CN¥792.50 Million 0.130x -25.68%
2023-12-31 CN¥5.42 Billion CN¥949.67 Million 0.175x +39.38%
2022-12-31 CN¥4.95 Billion CN¥622.09 Million 0.126x +441.93%
2021-12-31 CN¥4.42 Billion CN¥-162.44 Million -0.037x +79.87%
2020-12-31 CN¥3.99 Billion CN¥-728.15 Million -0.183x -280.76%
2019-12-31 CN¥5.94 Billion CN¥-284.94 Million -0.048x -143.47%
2018-12-31 CN¥6.28 Billion CN¥692.72 Million 0.110x +452.97%
2017-12-31 CN¥7.48 Billion CN¥149.22 Million 0.020x -94.04%
2016-12-31 CN¥8.30 Billion CN¥2.78 Billion 0.335x +50.91%
2015-12-31 CN¥7.48 Billion CN¥1.66 Billion 0.222x +71.25%
2014-12-31 CN¥8.77 Billion CN¥1.14 Billion 0.130x +702.39%
2013-12-31 CN¥8.77 Billion CN¥141.64 Million 0.016x -74.96%
2012-12-31 CN¥8.65 Billion CN¥557.83 Million 0.064x +1410.01%
2011-12-31 CN¥6.41 Billion CN¥-31.56 Million -0.005x -102.79%
2010-12-31 CN¥6.55 Billion CN¥1.15 Billion 0.176x -43.08%
2009-12-31 CN¥5.98 Billion CN¥1.85 Billion 0.309x +209.57%
2008-12-31 CN¥5.79 Billion CN¥578.59 Million 0.100x -22.30%
2007-12-31 CN¥5.05 Billion CN¥650.16 Million 0.129x -13.48%
2006-12-31 CN¥4.96 Billion CN¥738.08 Million 0.149x -13.82%
2005-12-31 CN¥4.39 Billion CN¥757.76 Million 0.173x +352.24%
2004-12-31 CN¥3.91 Billion CN¥149.01 Million 0.038x -60.58%
2003-12-31 CN¥3.13 Billion CN¥302.83 Million 0.097x -27.37%
2002-12-31 CN¥2.88 Billion CN¥383.44 Million 0.133x -40.95%
2001-12-31 CN¥2.68 Billion CN¥604.13 Million 0.226x -32.31%
2000-12-31 CN¥1.63 Billion CN¥541.70 Million 0.333x +14.09%
1999-12-31 CN¥1.48 Billion CN¥431.22 Million 0.292x +67.75%
1998-12-31 CN¥1.27 Billion CN¥221.41 Million 0.174x --